- Home
- GNFT vs ZYXI Comparison
GNFT vs ZYXI Comparison
Compare GNFT & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- ZYXI
- Stock Information
- Founded
- GNFT 1999
- ZYXI 1996
- Country
- GNFT France
- ZYXI United States
- Employees
- GNFT N/A
- ZYXI N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GNFT Health Care
- ZYXI Health Care
- Exchange
- GNFT Nasdaq
- ZYXI Nasdaq
- Market Cap
- GNFT 249.0M
- ZYXI 257.1M
- IPO Year
- GNFT 2019
- ZYXI N/A
- Fundamental
- Price
- GNFT $5.39
- ZYXI $7.90
- Analyst Decision
- GNFT Strong Buy
- ZYXI Strong Buy
- Analyst Count
- GNFT 1
- ZYXI 2
- Target Price
- GNFT $13.00
- ZYXI $14.00
- AVG Volume (30 Days)
- GNFT 20.1K
- ZYXI 91.6K
- Earning Date
- GNFT 09-19-2024
- ZYXI 10-24-2024
- Dividend Yield
- GNFT N/A
- ZYXI N/A
- EPS Growth
- GNFT N/A
- ZYXI N/A
- EPS
- GNFT 0.47
- ZYXI 0.18
- Revenue
- GNFT $86,225,222.00
- ZYXI $193,614,000.00
- Revenue This Year
- GNFT $155.44
- ZYXI $11.68
- Revenue Next Year
- GNFT N/A
- ZYXI $20.90
- P/E Ratio
- GNFT $11.07
- ZYXI $43.53
- Revenue Growth
- GNFT 175.45
- ZYXI 9.11
- 52 Week Low
- GNFT $2.89
- ZYXI $7.04
- 52 Week High
- GNFT $6.05
- ZYXI $13.77
- Technical
- Relative Strength Index (RSI)
- GNFT 60.67
- ZYXI 46.50
- Support Level
- GNFT $5.06
- ZYXI $7.70
- Resistance Level
- GNFT $6.05
- ZYXI $8.45
- Average True Range (ATR)
- GNFT 0.31
- ZYXI 0.31
- MACD
- GNFT 0.04
- ZYXI -0.02
- Stochastic Oscillator
- GNFT 65.60
- ZYXI 22.47
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.